已收录 273199 条政策
 政策提纲
  • 暂无提纲
Monocytes-based in vitro assay for a preliminary biocompatibility assessment of blood-contacting devices
[摘要] The biological evaluation of biomaterials is currently defined by the ISO-10993 norm in which parts four and five are dedicated to emo-compatibility and cell toxicity, respectively. Our study will provide a novel in vitro experimental approach for the biocompatibility assessment of biomaterials or medical devices using human primary monocytes as cellular model. In these new settings, human monocytes are exposed to a medium containing the extractable compounds derived from materials or devices; subsequently, cell toxicity and pro-inflammatory effects are analysed through MTT assay, flow cytometry and enzyme-linked immunosorbent assay (ELISA) methodologies. These experimental procedures offer the advantage to use a human and primary cell context belonging to the immune system, in order to accurately predict the nature of blood/device interaction occurring during a clinical application. To validate the reliability of this method, we also reported a comparative study between two different membranes showing a different level of biocompatibility. On the bases of these data, it is possible to state that this new experimental model represents a good approach to investigate the effects induced by a biomaterial on cell death and inflammation using human, primary monocytes.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 内科医学
[关键词] biocompatibility;biomaterials;blood-contacting devices;cell toxicity;extractable compound;inflammation;medical devices;monocytes [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文